Target intelligence / Profile preview

RNA, U6 small nuclear 878, pseudogene (RNU6-878P)

Target
RNU6-878P
Molecular classification
Other (Pseudogene of small nuclear RNA)
01

Overview

RNU6-878P is a **pseudogene** of the **U6 small nuclear RNA (snRNA) family**[3]. U6 snRNA itself is an essential part of the spliceosome, the complex responsible for intron removal during pre-mRNA splicing in eukaryotes[5][7]. U6-derived pseudogenes like RNU6-878P result from genomic duplications or retrotranspositions but do not encode functional RNA or protein products. These pseudogenes lack promoter elements or accumulate mutations preventing their expression or function. While the broader U6 family is highly conserved due to its key catalytic role in splicing, the pseudogene copies are generally considered non-functional genomic elements[5][7]. There is no evidence that RNU6-878P is expressed or has a direct biological, pathological, or therapeutic relevance at this time[3][4].\n\nSummary: \nRNU6-878P is a non-coding, non-functional pseudogene related to the U6 snRNA; it is not considered a therapeutic target, biomarker, or disease-relevant molecule, and does not interact with any drugs[3][4][5].

Other names
RNU6-878P
02

Mechanism of action

None known

03

Biological functions

No known direct biological function; pseudogenes do not typically have a functional gene product[3].
04

Disease associations

Other (There is no evidence for RNU6-878P specifically having a defined role in disease; in general, pseudogenes may contribute to regulatory roles or, rarely, be implicated through genomic rearrangement, but this is not documented for RNU6-878P)[4].
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, U6 small nuclear 878, pseudogene (RNU6-878P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 878, pseudogene (RNU6-878P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call